Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

11.81
Delayed Data
As of Sep 03
 -0.55 / -4.45%
Today’s Change
11.77
Today|||52-Week Range
23.99
-47.39%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close12.36
Today’s open12.38
Day’s range11.77 - 12.57
Volume356,911
Average volume (3 months)243,274
Market cap$362.8M
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)-120.60%
Earnings growth (this year)+33.53%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.79

Competitors

 Today’s
change
Today’s
% change
ADMSAdamas Pharmaceutica...-0.86-4.35%
CNCEConcert Pharmaceutic...-0.80-4.86%
ITEKInotek Pharmaceutica...-0.85-6.08%
IDRAIdera Pharmaceutical...-0.06-2.03%
Data as of 3:59pm ET, 09/03/2015

Financials

Next reporting dateNovember 5, 2015
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$0.00
Annual profit (last year)-$57.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts

Partner Offers